Register | Login
Intellectual Property Today
RFC Express - Document Management System
2013 Top Patent Firms
2013 Top Trademark Firms
Current Issue

Advertising Opportunities

Click Here

Email A Friend Back to Archived News

Redpoint Bio Corporation Receives Two U.S. Patents Covering Compositions and Methods for Low-Sodium Salt Substitute

Monday, December 01, 2008

Ewing, NJ -- Redpoint Bio Corporation (OTCBB: RPBC), a company developing ingredients to improve the taste of pharmaceutical, food and beverage products, today announced the issuance of Patents No. 7,452,563 and 7,455,872, by the U.S. Patent and Trademark Office, covering compositions and methods for its low-sodium salt substitute called Betrasalt®.

Betrasalt® contains a proprietary formulation of FEMA GRAS materials that mitigates the bitter and metallic taste of potassium chloride (KCl), the active ingredient used in many salt-substitute products. Redpoint’s Betrasalt® formulation retains the cooking functionality and preservative qualities of common table salt (sodium chloride) with an improved taste profile as compared to potassium chloride alone. Redpoint Bio currently owns or has exclusive licenses to a total of 11 issued U.S. patents and 15 issued foreign patents primarily addressing taste modification. In addition, the Company has over 70 U.S. and foreign patent applications pending.

"Individuals in the United States consume, on average, over 4,000 milligrams of sodium per day, well over the maximum consumption level of 2,300 milligrams per day recommended by The Dietary Guidelines for Americans, 2005 published by the Department of Health and Human Services (HHS) and the Department of Agriculture (USDA)," said Dr. Raymond Salemme, Chief Executive Officer of Redpoint Bio. "Excess dietary salt is thought to be a contributor to hypertension and associated cardiovascular diseases that are linked to high morbidity and increased healthcare costs. Redpoint is actively seeking potential partners interested in commercializing the Betrasalt technology."

About Redpoint Bio Corporation

Redpoint Bio is leveraging recent discoveries in the molecular biology of taste to discover and develop novel taste enhancers and aversive taste blockers for the food, beverage and pharmaceutical industries. Redpoint Bio's food and beverage program is focused on identifying flavor enhancers that improve the taste of existing ingredients, reduce the need for excess sugar and salt, and contribute to the development of healthier, better-tasting foods and beverages. The pharmaceutical program uses a biochemical approach aimed at suppressing the bitterness of medicines, which has the potential to expand the range of formulation options and increase patient compliance. For more information, please visit the Company's website at

Safe Harbor Statement

In addition to historical facts or statements of current condition, this press release contains forward-looking statements within the meaning of the "Safe Harbor" provisions of The Private Securities Litigation Reform Act of 1995. Forward-looking statements provide the Company's current expectations or forecasts of future events. The Company's performance and financial results could differ materially from those reflected in these forward-looking statements due to among other factors, uncertainty inherent in the discovery phase of technological development, any efforts by third parties to invalidate or limit any patents, the marketplace acceptance of its products, the decisions of regulatory authorities, the results of clinical trials and general financial, economic, regulatory and political conditions affecting the food and beverage, biotechnology and pharmaceutical industries generally. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. The Company undertakes no obligation to update publicly any forward-looking statement.

Back to Archived News
Looking for...

  © Copyright 2013 Intellectual Property Today
Download Adobe Reader for free